Cargando…

Tumor metabolism derived from (18)F-FDG PET/CT in predicting the macrotrabecular-massive subtype of hepatocellular carcinoma

BACKGROUND: The recently described pathological subtype of hepatocellular carcinoma (HCC), named macrotrabecular massive (MTM), is associated with an unfavorable prognosis. This study aimed to evaluate the potential for tumor metabolism obtained by β-2-[18F] fluoro-2-deoxy-D-glucose positron emissio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Siqi, Xie, Yujie, Yang, Ting, Yang, Yuan, Zou, Qiong, Jiao, Ju, Zhang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816756/ https://www.ncbi.nlm.nih.gov/pubmed/36620154 http://dx.doi.org/10.21037/qims-22-523

Ejemplares similares

Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma
por: Shan, Yuying, et al.
Publicado: (2022)

Macrotrabecular-massive subtype-based nomogram to predict early recurrence of hepatocellular carcinoma after surgery
por: Yang, Yong, et al.
Publicado: (2023)

Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype
por: Yang, Lili, et al.
Publicado: (2023)

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
por: Li, Xiaoming, et al.
Publicado: (2022)

Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge
por: Sessa, Anna, et al.
Publicado: (2022)

Recognising the clinically significant macrotrabecular massive variant of hepatocellular carcinoma
por: Seow, Dominique Yuan Bin, et al.
Publicado: (2022)

Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study
por: He, Chutong, et al.
Publicado: (2023)

Development and validation of MRI-based model for the preoperative prediction of macrotrabecular hepatocellular carcinoma subtype
por: Bilal Masokano, Ismail, et al.
Publicado: (2022)

Perfusion CT and PET with 18F–FDG and 18F–FCh in the complex diagnosis of hepatocellular carcinoma
por: Tulin, P. E., et al.
Publicado: (2017)

Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on (18)F-FDG PET/CT
por: Erdoğan, Ezgi Başak, et al.
Publicado: (2018)

(68)Ga-PSMA PET/CT Versus (18)F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2020)

Comparison of computed tomography and magnetic resonance imaging findings and histopathological features of macrotrabecular-massive hepatocellular carcinoma
por: Gong, Qishu, et al.
Publicado: (2023)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
por: Zhang, Yang, et al.
Publicado: (2023)

Preoperative (18)F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma
por: Choi, Wookjin, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

The significance of (18)F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis
por: Zhang, Li-Juan, et al.
Publicado: (2012)

Solitary sternal metastasis from hepatocellular carcinoma detected by F-18 FDG PET/CT
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2013)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
por: Mistry, Vijay, et al.
Publicado: (2023)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Crossed cerebellar diaschisis on F-18 FDG PET/CT
por: Agrawal, Kanhaiya Lal, et al.
Publicado: (2011)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Hepatosplenic Candidiasis Detected by (18)F-FDG-PET/CT
por: Albano, Domenico, et al.
Publicado: (2016)

18F-FDG PET/CT in the diagnosis of Takayasu’s arteritis
por: Sargin, Gokhan, et al.
Publicado: (2018)

Fasting Hypoglycemia on (18)F-FDG PET/CT Scan
por: Nakayama, Michihiro, et al.
Publicado: (2017)

(18)F-FDG PET/CT Findings in Cytomegalovirus Colitis
por: Kjaer, Anna Sophie L., et al.
Publicado: (2018)

Incidental “Urinoma” in (18)F-FDG PET/CT Scan
por: Gültekin, Aziz, et al.
Publicado: (2019)

F-18-FDG PET/CT findings of paraneoplastic dermatoses
por: Suga, Kazuyoshi
Publicado: (2022)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

Usefulness of (18)F-FDG PET/CT and Multiphase CT in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Carcinoma-Cholangiocarcinoma
Publicado: (2020)

Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2023)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oqs4h20gsg8hgirtecbe4s82ct